Recon: China suspends sale of Sun dementia drug; Intellia cleared to resume gene therapy trial after FDA hold

• In major test for longevity field, FDA greenlights study on a 'near total reset' of cells (STAT)
• IRA drug pricing petitions pile up at the Supreme Court (STAT)
• Insurance CEOs In The Hot Seat: House Hearings Emphasize Rx Access, Not Prices (Pink Sheet)
• Pfizer retains top spot in vaccine rankings as Sanofi slides (Fierce Pharma)

• China halts sale of Sun Pharma drug used to treat dementia (Reuters) (Fierce Pharma)
• Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere (Endpoints)
• UK and US biotech investor Epidarex raises $145M for fourth fund (Endpoints)
• Swiss CDMO Siegfried gains 3 sites through M&A, including 2 in US (Fierce Pharma)
• Catalent plans to close Belgium cell therapy site that employs 150 workers (Endpoints)
• Indian diagnostic services chain Orange Health eyes profitability in early 2028 (Reuters)
• EU-India trade pact to largely cull 11% tariff on European drugs (Fierce Pharma)
• Servier revenue growth hits 16% as group eyes €10B 2030 goal (Fierce Pharma)
• No Nipah virus cases detected in China, state media says (Reuters)

• Roche moves obesity drug to pivotal trials after mid-stage success (STAT) (Reuters)
• Virtual women’s health company Wisp buys TBD Health (Endpoints)
• TRexBio gets another $50M to bring more Treg candidates into the clinic (Endpoints)
• Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme (Endpoints)
• Intellia gets FDA nod to resume gene therapy trial after safety pause (Reuters)
• Andreessen Horowitz Invests Early in Swedish AI Startup Dentio (Bloomberg)
• Teva taps Will Forte to join Huntington’s disease awareness push (Fierce Pharma)

• Former executives of device maker Zynex Medical indicted for fraud (STAT)
• 5 robotic surgery trends to watch in 2026 (MedTech Dive)
• FDA guidance eases wearables oversight. But experts have questions about what’s next. (MedTech Dive)
• Medtronic targets ASCs with extended Mindray collaboration (MedTech Dive)

• Food and beverage brands adopt new non-ultraprocessed label (Food Dive)
• Small and local food brands stand out at grocery stores (Food Dive)

• 9 influencers shaping health information online, for better or worse (STAT)
• Hospital group wants Trump administration to block a new Lilly policy on 340B claims data (STAT)
• Sidelining Black women in clinical trials is not just a moral failure. It’s bad science (STAT)
• Trump administration proposes tiny pay raise to 2027 Medicare Advantage plans (STAT)
• UnitedHealth tumbles as Medicare insurer payment rates, 2026 revenue forecast disappoint (Reuters)